Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Germany / NCT05585593
Recruiting Observational

Registry for Hypoparathyroidism Wuerzburg

NCT05585593 · tracked via the Priya Life Science Germany tracker
Sponsor
University of Wuerzburg
Phase
Observational
Started
2017-10-18
Last updated
2022-11-08

Condition(s) studied

Comorbidities and Coexisting ConditionsMoralityHypocalcemiaHypercalcemiaQuality of Life

Study summary

Long-term conventional treatment of chronic hypoparathyroidism does not fully restore calcium homeostasis leading to increased morbidity, emergency events and reduced subjective health status. To further investigate general morbidity, hypocalcemic events, subjective and daily life performance in patients with chronic hypoparathyroidism a standardized interview as well as blood sampling and examinations such as echocardiography and renal ultrasound are performed.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * age of 18 * chronic hypoparathyroidism (\>12 months) under established therapy or chronic pseudohypoparathyroidism (\>12 months) under established therapy * written informed consent Exclusion Criteria: * age \<18 years * no detailed documentation of hypo- or pseudohypoparathyroidism

Primary outcome measure(s)

  • Comorbidites — 15 years
    Comorbidities such as renal diseases, cardiovascular disease, psychiatric diseases under treatment
  • Subjective health status — 15 years
    Assessment of the subjective health status by standardized quality of life (QoL) questionnaires (e.g. short form-36, Patient Health Questionnaire 28)

Trial sites (1)

FacilityCityRegionStatus
Dept. of Endocrinology and Diabetology, Dept. of Medicine I, University Hospital Wuerzburg Würzburg Bavaria Recruiting

More University of Wuerzburg trials in Germany

Adrenal Tumors - Pathogenesis and Therapy Recruiting
Effects of Isolated Lumbar Extension Resistance Training Alone and in Combination with General Exercise and Manual Therapy Active, not recruiting
German Adrenocortical Carcinoma Registry Recruiting
I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer Active, not recruiting
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma Active, not recruiting

Other trials for the same condition

Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO ) Recruiting
International CIPN Assessment and Validation Study Recruiting
Causes, Characteristics and Treatment of Hypercalcemia in the Emergency Room of a German Hospital Active, not recruiting
Evaluation of the Epilepsy-related Quality of Life, Seizure-related Accidents and Validation of the Mjn-SERAS Solution in the Normalised Patient Environment with Real-World Data Recruiting
Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05585593 on ClinicalTrials.gov ↗ ← All trials in Germany